IDIBELL’s spin-off Aptadel Therapeutics develops RNA-based molecules to find alternative treatments against cancer that are more effective and less toxic than current ones.
Read moreEl estudio servirá de base a dos ensayos internacionales para comprobar la eficacia del fármaco Azeliragon en estos tumores cerebrales agresivos
Read moreThe latest call for independent research project grants from the Carlos III Health Institute has selected three projects led by researchers from the Hospital del Mar Research Institute. These projects...
Read moreThe creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translational research, innovation and training on a single c...
Read moreEl Instituto de Neurociencias de Castilla y León (INCYL) trabaja en una línea de investigación contra el glioblastoma y ha logrado resultados prometedores
Read moreBiotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non-specific treatments to those tailored to the unique characteristics of each patient. ...
Read moreIn the frame of World Cancer Day, held on 4th February, various research projects at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) stand out for their efforts to find new therapeutic s...
Read moreDemuestran que cambios en el estrés osmótico de las células tumorales pueden generar resistencia o sensibilidad a fármacos antitumorales, en función de la naturaleza de estos.
Read moreLa Asociación Española contra el Cáncer en Navarra celebra el Día Mundial contra el Cáncer con la entrega de las Ayudas AECC 2024, que apuestan por el trabajo investigador en tumores de baja supe...
Read moreThe study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial ener...
Read moreThe device Micro Immune Response On chip (MIRO), which has already been successfully tested on breast cancer samples, could be key to developing new treatments and determining the most appropriate the...
Read morePublished in Cell Reports Medicine*, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and tr...
Read more